PL3518905T3 - Farmaceutyczne kompozycje antagonisty 5-ht6 - Google Patents

Farmaceutyczne kompozycje antagonisty 5-ht6

Info

Publication number
PL3518905T3
PL3518905T3 PL17794060T PL17794060T PL3518905T3 PL 3518905 T3 PL3518905 T3 PL 3518905T3 PL 17794060 T PL17794060 T PL 17794060T PL 17794060 T PL17794060 T PL 17794060T PL 3518905 T3 PL3518905 T3 PL 3518905T3
Authority
PL
Poland
Prior art keywords
antagonist
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
PL17794060T
Other languages
English (en)
Inventor
Ramakrishna Nirogi
Koteshwara Mudigonda
Dhanunjay Kumar DOGIPARTI
Venkateswarlu Jasti
Original Assignee
Suven Life Sciences Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Limited filed Critical Suven Life Sciences Limited
Publication of PL3518905T3 publication Critical patent/PL3518905T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL17794060T 2016-10-03 2017-09-29 Farmaceutyczne kompozycje antagonisty 5-ht6 PL3518905T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201641033741 2016-10-03
PCT/IB2017/056009 WO2018065869A1 (en) 2016-10-03 2017-09-29 Pharmaceutical compositions of 5-ht6 antagonist
EP17794060.8A EP3518905B1 (en) 2016-10-03 2017-09-29 Pharmaceutical compositions of 5-ht6 antagonist

Publications (1)

Publication Number Publication Date
PL3518905T3 true PL3518905T3 (pl) 2021-10-25

Family

ID=60245136

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17794060T PL3518905T3 (pl) 2016-10-03 2017-09-29 Farmaceutyczne kompozycje antagonisty 5-ht6

Country Status (25)

Country Link
US (1) US20190336497A1 (pl)
EP (1) EP3518905B1 (pl)
JP (1) JP6669937B2 (pl)
KR (1) KR102083135B1 (pl)
CN (1) CN109789098A (pl)
AU (1) AU2017339755B2 (pl)
CA (1) CA3038620C (pl)
CY (1) CY1124539T1 (pl)
DK (1) DK3518905T3 (pl)
EA (1) EA036235B1 (pl)
ES (1) ES2879675T3 (pl)
HR (1) HRP20211092T1 (pl)
HU (1) HUE055452T2 (pl)
IL (1) IL265662B (pl)
LT (1) LT3518905T (pl)
MA (1) MA46358B1 (pl)
MD (1) MD3518905T2 (pl)
MX (1) MX386462B (pl)
PL (1) PL3518905T3 (pl)
PT (1) PT3518905T (pl)
RS (1) RS62113B1 (pl)
SI (1) SI3518905T1 (pl)
SM (1) SMT202100403T1 (pl)
WO (1) WO2018065869A1 (pl)
ZA (1) ZA201901734B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019008484A1 (en) * 2017-07-03 2019-01-10 Suven Life Sciences Limited NEW USES OF A PURE 5-HT6 RECEPTOR ANTAGONIST

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1581492B1 (en) * 2002-11-28 2008-07-16 Suven Life Sciences Limited N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
AU2003292510B2 (en) * 2002-12-18 2009-04-23 Suven Life Sciences Limited Tetracyclic 3-substituted indoles having serotonin receptor affinity
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
MX364930B (es) * 2013-12-02 2019-05-14 Suven Life Sciences Ltd Proceso de producción a gran escala de dimesilato de 1-[(2-bromofenil]sulfonil]-5-metoxi-3-[(4-metil-1-piperazinil)met il]-1h-indol monohidratado.

Also Published As

Publication number Publication date
EA201990827A1 (ru) 2019-07-31
MX2019003815A (es) 2019-08-12
EP3518905A1 (en) 2019-08-07
CA3038620C (en) 2020-05-26
WO2018065869A1 (en) 2018-04-12
ZA201901734B (en) 2020-11-25
KR20190050858A (ko) 2019-05-13
AU2017339755A1 (en) 2019-04-18
CY1124539T1 (el) 2022-07-22
ES2879675T3 (es) 2021-11-22
NZ752060A (en) 2020-09-25
SI3518905T1 (sl) 2021-11-30
CN109789098A (zh) 2019-05-21
HRP20211092T1 (hr) 2021-10-15
MX386462B (es) 2025-03-19
HUE055452T2 (hu) 2021-11-29
RS62113B1 (sr) 2021-08-31
SMT202100403T1 (it) 2021-09-14
JP6669937B2 (ja) 2020-03-18
LT3518905T (lt) 2021-08-10
PT3518905T (pt) 2021-07-14
CA3038620A1 (en) 2018-04-12
KR102083135B1 (ko) 2020-02-28
MA46358B1 (fr) 2021-08-31
EP3518905B1 (en) 2021-04-28
MD3518905T2 (ro) 2021-09-30
IL265662B (en) 2019-11-28
BR112019006588A2 (pt) 2019-07-02
EA036235B1 (ru) 2020-10-16
IL265662A (en) 2019-05-30
US20190336497A1 (en) 2019-11-07
JP2019529471A (ja) 2019-10-17
DK3518905T3 (da) 2021-07-19
AU2017339755B2 (en) 2019-11-07

Similar Documents

Publication Publication Date Title
IL279464A (en) Pharmaceutical formulation of odevixibat
ZA201802199B (en) Pharmaceutical compositions of il-2
SG11201706123XA (en) Pharmaceutical compositions comprising meloxicam
GB201608323D0 (en) Pharmaceutical compositions
IL273259A (en) Production of pharmaceutical preparations
IL248090A0 (en) Solid pharmaceutical preparations containing biopterin derivatives and their uses
ZA201606075B (en) Pharmaceutical compositions of sitagliptin
GB201705303D0 (en) Pharmaceutical compositions
GB201705304D0 (en) Pharmaceutical compositions
GB201705305D0 (en) Pharmaceutical compositions
GB201705306D0 (en) Pharmaceutical compositions
IL267279A (en) Pharmaceutical formulations of suvorexant
IL263999A (en) Pharmaceutical compositions
IL265662B (en) Pharmaceutical preparation of 5-HT6 antagonist
ZA201705782B (en) Pharmaceutical compositions
ZA201705783B (en) Pharmaceutical compositions
GB201715881D0 (en) New pharmaceutical compositions
GB201700831D0 (en) Pharmaceutical compositions
GB201710114D0 (en) Pharmaceutical compositions
GB201706816D0 (en) Pharmaceutical compositions
GB201705302D0 (en) Pharmaceutical compositions
GB201705301D0 (en) Pharmaceutical compositions
GB201608393D0 (en) Solid pharmaceutical compositions
HRP20220610T8 (hr) Farmaceutski pripravci koji sadrže meloksikam